{
    "title": "103_hr1926",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``National Narcotics Leadership Act \nAmendments of 1993''.\n\nSEC. 2. IMPLEMENTATION OF NATIONAL DRUG CONTROL STRATEGY.\n\n    Section 1003(c) of the National Narcotics Leadership Act of 1988 \n(21 U.S.C. 1502(c)) is amended--\n            (1) by redesignating paragraphs (5), (6), and (7) as \n        paragraphs (6), (7), and (8), respectively; and\n            (2) by inserting after paragraph (4) the following:\n    ``(5) The Director may require the inclusion, in the budget \nsubmission to the Office of Management and Budget by any National Drug \nControl Program agency, of funding requests for specific initiatives \nthat are consistent with the President's priorities for the National \nDrug Control Strategy and certifications made pursuant to paragraph \n(3).''.\n\nSEC. 3. REPORT ON REPROGRAMMING; OFFICE PERSONNEL RESTRICTION.\n\n    (a) Report on Reprogramming.--Section 1003(c)(7) of the National \nNarcotics Leadership Act of 1988, as redesignated by section 2(1) of \nthis Act, is amended to read as follows:\n    ``(7) The Director shall report to the Congress on a quarterly \nbasis regarding the need for any reprogramming or transfer of \nappropriated funds in an amount greater than $5,000,000 for National \nDrug Control Program activities.''.\n    (b) Office Personnel Restriction.--Section 1003 of the National \nNarcotics Leadership Act of 1988 (21 U.S.C. 1502) is amended by adding \nat the end the following:\n    ``(f) Prohibition on Political Campaigning.--A Federal officer in \nthe Office of National Drug Control Policy who is appointed by the \nPresident, by and with the advice and consent of the Senate, may not \nparticipate in Federal election campaign activities, except that such \nan official is not prohibited by this subsection from making \ncontributions to individual candidates.''.\n\nSEC. 4. NATIONAL DRUG CONTROL STRATEGY OUTCOME MEASURES.\n\n    Section 1005(a) of the National Narcotics Leadership Act of 1988 \n(21 U.S.C. 1504(a)) is amended--\n            (1) in paragraph (2)(A) by inserting ``and the consequences \n        of drug abuse'' after ``drug abuse''; and\n            (2) by amending paragraph (4) to read as follows:\n            ``(4) The Director shall include with each National Drug \n        Control Strategy an evaluation of the effectiveness of Federal \n        drug control during the preceding year. The evaluation shall \n        include an assessment of Federal drug control efforts, \n        including--\n                    ``(A) assessment of the reduction of drug use, \n                including estimates of drug prevalence and frequency of \n                use as measured by national, State, and local surveys \n                of illicit drug use and by other special studies of--\n                            ``(i) high-risk populations, including \n                        school dropouts, the homeless and transient, \n                        arrestees, parolees, and probationers, and \n                        juvenile delinquents; and\n                            ``(ii) drug use in the workplace and the \n                        productivity lost by such use;\n                    ``(B) assessment of the reduction of drug \n                availability, as measured by--\n                            ``(i) the quantities of cocaine, heroin, \n                        and marijuana available for consumption in the \n                        United States;\n                            ``(ii) the amount of cocaine and heroin \n                        entering the United States;\n                            ``(iii) the number of hectares of poppy and \n                        coca cultivated and destroyed;\n                            ``(iv) the number of metric tons of heroin \n                        and cocaine seized;\n                            ``(v) the number of cocaine processing labs \n                        destroyed;\n                            ``(vi) changes in the price and purity of \n                        heroin and cocaine;\n                            ``(vii) the amount and type of controlled \n                        substances diverted from legitimate retail and \n                        wholesale sources; and\n                            ``(viii) the effectiveness of Federal \n                        technology programs at improving drug detection \n                        capabilities at United States ports of entry;\n                    ``(C) assessment of the reduction of the \n                consequences of drug use and availability, which shall \n                include estimation of--\n                            ``(i) burdens drug users placed on hospital \n                        emergency rooms in the United States, such as \n                        the quantity of drug-related services provided;\n                            ``(ii) the annual national health care \n                        costs of drug use, including costs associated \n                        with people becoming infected with the human \n                        immunodeficiency virus and other communicable \n                        diseases as a result of drug use;\n                            ``(iii) the extent of drug-related crime \n                        and criminal activity; and\n                            ``(iv) the contribution of drugs to the \n                        underground economy, as measured by the retail \n                        value of drugs sold in the United States; and\n                    ``(D) determination of the status of drug treatment \n                in the United States, by assessing--\n                            ``(i) public and private treatment capacity \n                        within each State, including information on the \n                        number of treatment slots available in relation \n                        to the number actually used, including data on \n                        intravenous drug users and pregnant women;\n                            ``(ii) the extent, within each State, to \n                        which treatment is available, on demand, to \n                        intravenous drug users and pregnant women;\n                            ``(iii) the number of drug users the \n                        Director estimates could benefit from \n                        treatment; and\n                            ``(iv) the success of drug treatment \n                        programs, including an assessment of the \n                        effectiveness of the mechanisms in place \n                        federally, and within each State, to determine \n                        the relative quality of substance abuse \n                        treatment programs, the qualifications of \n                        treatment personnel, and the mechanism by which \n                        patients are admitted to the most appropriate \n                        and cost effective treatment setting.\n            ``(5) The Director shall include with the National Drug \n        Control Strategy required to be submitted not later than \n        February 1, 1994, and with every second such strategy submitted \n        thereafter--\n                    ``(A) an assessment of the quality of current drug \n                use measurement instruments and techniques to measure \n                supply reduction and demand reduction activities;\n                    ``(B) an assessment of the adequacy of the coverage \n                of existing national drug use measurement instruments \n                and techniques to measure the casual drug user \n                population and groups at-risk for drug use;\n                    ``(C) an assessment of the actions the Director \n                shall take to correct any deficiencies and limitations \n                identified pursuant to subparagraphs (A) and (B); and\n                    ``(D) identification of the specific factors that \n                restrict the availability of treatment services to \n                those seeking it and proposed administrative or \n                legislative remedies to make treatment available to \n                those individuals.\n            ``(6) Federal agencies responsible for the collection or \n        estimation of drug-related information required by the Director \n        shall cooperate with the Director, to the fullest extent \n        possible, to enable the Director to satisfy the requirements of \n        sections 4 and 5.\n            ``(7) By June 1, 1994, and with each National Drug Control \n        Strategy submitted thereafter, the Director shall report to the \n        President and the Congress on the Director's assessment of drug \n        use and availability in the United States, including an \n        estimate of the effectiveness of interdiction, treatment, \n        prevention, law enforcement, and international programs under \n        the National Drug Control Strategy in effect in the preceding \n        year in reducing drug use and availability.''.\n\nSEC. 5. DIRECTOR AS A MEMBER OF THE NATIONAL SECURITY COUNCIL.\n\n    Section 402(a)(7) of title 50, United States Code, is amended by--\n            (1) striking ``and'' after the semicolon in paragraph (6);\n            (2) redesignating paragraph (7) as paragraph (8); and\n            (3) inserting after paragraph (6) the following:\n            ``(7) the Director of the Office of National Drug Control \n        Policy; and''.\n\nSEC. 6. COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER.\n\n    (a) Drug Abuse Addiction and Rehabilitation Center.--Section 1003A \nof the National Narcotics Leadership Act of 1988 (21 U.S.C. \n1502a(c)(1)) is amended--\n            (1) by redesignating subparagraphs (B), (C), and (D) as \n        subparagraphs (C), (D), and (E), respectively; and\n            (2) by inserting after subparagraph (A) the following:\n                    ``(B) identify and support, through interagency \n                agreements or grants that are subjected to peer review \n                by independent advisory boards, the application of \n                technology to expanding the effectiveness or \n                availability of drug treatment;''.\n    (b) Assistance From the Advanced Research Project Agency.--Section \n1003A of the National Narcotics Leadership Act of 1988 (21 U.S.C. \n1502a) is amended by adding at the end the following:\n    ``(f) Assistance and Support to Office of National Drug Control \nPolicy.--The Director of the Advanced Research Project Agency shall, to \nthe fullest extent possible, render assistance and support to the \nOffice of National Drug Control Policy and its Director.''.\n    (c) Repeal and Redesignation.--The National Narcotics Leadership \nAct of 1988 is amended by--\n            (1) repealing section 1008 (21 U.S.C. 1505), as in effect \n        on the date of the enactment of this Act;\n            (2) redesignating section 1003A, as amended by subsection \n        (b) of this section, as section 1008; and\n            (3) moving such section, as redesignated, so as to follow \n        section 1007.\n\nSEC. 7. PAYING CERTAIN NECESSARY EXPENSES FOR STRATEGY CONSULTATION.\n\n    Section 1005(a)(3) of the National Narcotics Leadership Act of 1988 \n(21 U.S.C. 1504(a)(3)) is amended by adding at the end the following:\n    ``(C) The Director may pay for the necessary and appropriate \nexpenses for assemblages of individuals providing consultation to the \nDirector in developing the National Drug Control Strategy.''.\n\nSEC. 8. AUTHORIZATION OF APPROPRIATIONS.\n\n    Section 1011 of the National Narcotics Leadership Act of 1988 (21 \nU.S.C. 1508) is amended by striking ``$3,500,000'' and all that follows \nthrough ``years,'' and inserting ``such sums as may be necessary for \nfiscal year 1994,''.\n\nSEC. 9. TERMINATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY.\n\n    Section 1009 of the National Narcotics Leadership Act of 1988 (21 \nU.S.C. 1506) is amended by striking ``the date which is 5 years after \nthe date of the enactment of this subtitle'' and inserting ``September \n30, 1994''.\n\n            Passed the House of Representatives November 21, 1993.\n\n            Attest:\n\n                                           DONNALD K. ANDERSON,\n\n                                                                 Clerk."
}